Transjugular intrahepatic portosystemic shunt: Efficacy for the treatment of portal hypertension and impact on liver transplantation

American Surgeon

Volumn 62, Issue 10, 1996, Pages 835-839

  Cosenza, Carlos A ^a   Hoffman, Allen L ^a,b   Friedman, Marc L ^a   Sher, Linda S ^a   Lofez, Richard R ^a   Van Allen, Richard ^a   Brown, Douglas H ^a   Fraiman, Mark H ^a   Arnaout, Walid ^a   Vierling, John ^a   Makowka, Leonard ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Comprehensive Liver Disease and Treatment Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT;

ADULT; AGED; ARTICLE; ASCITES; BLEEDING; CLINICAL ARTICLE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; MALE; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 10144229101     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Graham DY, Smith TL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-9.
2. Capone RR, Buhac I, Kohberger RC, et al. Resistant ascites in alcoholic liver cirrhosis: course and prognosis. Dig Dis Sci 1978;23:867-71.
3. Henderson JM, Gilmore GT, Hooks MA, et al. Selective shunt in the management of variceal bleeding in the era of liver transplantation. Ann Surg 1992;216:248-55
4. Rikkers LF, Sorell WT, Jin G. Which portosystemic shunt is best? Gastroenterol Clin North Am 1992;21:179-93.
5. Zemel G, Katzen BT, Becker GJ, et al. Percutaneous transjugular portosystemic shunt. JAMA 1991;266:390-3.
6. Simpson KJ, Chalmers N, Redhead DN, et al. Transjugular intrahepatic portosystemic stent shunting for the control of acute and recurrent upper gastrointestinal hemorrhage related to portal hypertension. Gut 1993;34:968-73.
7. Roessle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procédure for variceal bleeding. N Engl J Med 1994;330:165-71.
8. Ochs A, Roessle M, Haag K, et al. The transjugular intrahepatic portosystemic stent shunt procedure for refractory ascites. N Eng J Med 1995;332:1192-7.
9. van Hoek B, Lindor KD, Murtaugh PA, et al. The role of portosystemic shunts for variceal bleeding in the liver transplantation era. Arch Surg 1994;129:683-8.
10. Radosevich PM, LaBerge JM, Gordon RL. Current status and future possibilities of transjugular intrahepatic portosystemic shunts in the management of portal hypertension. World J Surg 1994; 18:785-9.
11. Martin M, Zajko AB, Orons PD, et al. Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: Indications and clinical results. Surgery 1993;! 14:719-27.
12. Helton WS, Belshaw A, Althaus S, et al. Critical appraisal of the angiographie portocaval shunt (TIPS). Am J Surg 1993; 165: 566-71.
13. Foster J, Delcore R, Payne KM, et al. The role of transjugular intrahepatic portosystemic shunts in the management of patients with end-stage liver disease. Am J Surg 1994;168:592-7.
14. Conn HO. Transjugular intrahepatic portal-systemic shunts: The state of the art. Hepatology 1993:17:149-58.
15. Sanyal AJ, Freedman AM, Shiffman ML, et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study. Hepatology 1994; 20:46-55.
16. Alvarez W, Piera C, Bandi JC, et al. Quantification of the extent of portosystemic shunting before and after TIPS. Relationship with portal-systemic encephalopathy. Hepatology 1995, 22: 296A.
17. Somberg KA, Riegler JL, LaBerge JM, et al. Hepatic en-cephalopathy after transjugular intrahepatic portosystemic shunt: Incidence and risk factors. Am J Gastroenterol 1995;90:549-55.
18. LaBerge JM, Somberg KA, Lake JR, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: Results in 90 patients. Gastroenterology 1995; 108:1143-51.
19. Lind CD, Malisch TW, Chong WK, et al. Incidence of shunt oclussion or stenosis following transjugular portosystemic shunt placement. Gastroenterology 1994;106:1277-83.
20. Shiffman ML, Jeffers L, Hoofnagle JH, et al. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the National Digestive Diseases Advisory Board. Hepatology 1995;22:1591-7.
21. Collins JC. Transjugular intrahepatic portosystemic shunts: Is TIPSS definitive therapy ? Am J Gastroenterol 1995;90:1913-4.
22. Eghtesad B, Bronsther O, Irish W, et al. Disease gravity and urgency as guidelines for liver allocation. Hepatology 1994, 20: 56S-62S.
23. Freedman AM, Sanyal AJ, Tisnado J, et al. Results with the percutaneous transjugular intrahepatic portosystemic stent-shunt for control of variceal hemorrhage in patients awaiting liver transplantation. Transplant Proc 1993;25:1087-9.
24. Ring EJ, Lake JR, Roberts JP, et al. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Int Med 1992;! 16:304-9.
25. Menegaux F, Baker E, Keeffe EB, et al. Impact of transjugular intrahepatic portosystemic shunt on orthotopic liver transplantation. World J Surg 1994;18:866-71.
26. Millis M, Imagawa D, Olthoff K, et al. TIPS: Impact on liver transplantation. Transplant Proc 1995;27:1252-3.
27. Quiroga J, Sangro B, Nunez M, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral and hemodynamic parameters. Hepatology 1995;21:986-94.
28. Ochs A, Gebbes AL, Haag K, et al. TIPS and paracentesis for the treatment of refractory ascites (RA): Interim analysis of a randomized controlled trial. Hepatology 1995, 22: 297A.